OVARIAN DYSFUNCTION

This adverse event was reported 50 times

These drugs are most commonly taken by patients reporting OVARIAN DYSFUNCTION:

# Drug Count
0 CYCLOPHOSPHAMIDE 25
1 CYCLOPHOSPHAMIDE FOR INJECTION 25
2 CYCLOPHOSPHAMIDE INJECTION, SOLUTION 25
3 BUSULFAN 15
4 ETOPOSIDE 8
5 FLUDARABINE PHOSPHATE 8
6 NIROGACESTAT 7
7 CARBOPLATIN 5
8 THIOTEPA 4
9 DOXORUBICIN 3
See all common drugs associated with OVARIAN DYSFUNCTION

OVARIAN DYSFUNCTION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 NIROGACESTAT 7 0.0076
1 BUSULFAN 15 0.0009
2 ESTRADIOL, FOLLICULINUM, OOPHORINUM (SUIS) 1 0.0004
3 THIOTEPA 4 0.0004
4 LOMUSTINE 1 0.0004
5 ELAGOLIX 1 0.0003
6 AMOXICILLIN AND CLAVULANATE POTASSIUM 1 0.0002
7 FLUDARABINE PHOSPHATE 8 0.0002
8 IFOSFAMIDE FOR INJECTION 3 0.0001
9 CYCLOPHOSPHAMIDE FOR INJECTION 25 0.0001
See all drugs enriched for association with OVARIAN DYSFUNCTION

OVARIAN DYSFUNCTION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Gamma Secretase Inhibitor [EPC] 7 0.0076
1 Alkylating Drug [EPC] 30 0.0001
2 Topoisomerase Inhibitor [EPC] 8 0.0001
3 Provitamin D2 Compound [EPC] 1 0.0000
4 B Lymphocyte Stimulator-specific Inhibitor [EPC] 1 0.0000
5 Platinum-based Drug [EPC] 6 0.0000
6 Purine Antimetabolite [EPC] 2 0.0000
7 Tetracycline-class Drug [EPC] 1 0.0000
8 Estrogen [EPC] 2 0.0000
9 Aminosalicylate [EPC] 1 0.0000
See all drug classes enriched for association with OVARIAN DYSFUNCTION